The company originally planned to complete its strategic review for the unit in the first half of 2023.
COVID-19 vaccines showed a decrease in all-cause mortality at 30 days and six months following AMI, according to the study.
Located in the Chakan Industrial Area of Pune, represents a major investment in the pursuit of scientific excellence, the company…
Nearly one in three adults are obese in the United Kingdom, the highest in Europe, according to a 2019 Organisation…
Moreover, these tests accompanied by a good diet and ample physical activity will keep you healthy while you age.
Also in August, the Danish company raised its profit and sales outlook for the year, citing growth fueled by demand…
Digital LifeCare is designed to help address the growing challenge of Non-Communicable Diseases (NCDs) on a population scale in India,…
Under our “New Ambition” phase of Strategy 2025, we are concentrating on five growth vectors globally, Subramanian told Financial Express.com.
Dengue in India: According to doctors, to expedite recovery from dengue, patients must prioritize rest, hydration, and close medical monitoring.
A study, published in March this year, pointed out that on an average, in families who had a member with…
The drugs were mentioned a combined 38 times on McKesson and Cencora’s recent earnings calls, versus nine times in the…
Last year, a nationwide shortage of infant formula occurred after cronobacter was discovered at an Abbott Laboratories facility.
In 2020, India accounted for about 82 percent of all malaria deaths and as many cases in South-East Asia.
On Wednesday, Médecins Sans Frontières (MSF) or Doctors Without Borders said it welcomed the big price drop, adding that it…
In order to eliminate the disease, the health ministry has come up with a renewed five-pronged strategy as part of…
GOQii Smart Healthcare strongly believes that preventive healthcare is the only viable, long-term, mass-market solution, it claimed.
This drug which is a monoclonal antibody enables one’s immune system to trace and destroy the cancerous cells. The drug…
Based on GlobalData’s analyst consensus forecast, global combined annual sales of Zejula and Zytiga will reach $2.5 billion by 2029.